Changeflow GovPing Healthcare & Life Sciences 36-Participant RCT Comparing Low-Dye and Calcan...
Routine Notice Added Final

36-Participant RCT Comparing Low-Dye and Calcaneal Taping for Plantar Fasciitis

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

A randomized controlled trial (NCT07544732) has been registered under the NIH ClinicalTrials.gov database, enrolling 36 participants with plantar fasciitis to compare Low-Dye taping versus Calcaneal taping over a two-week intervention period. The study will measure pain using the Visual Analogue Scale (VAS), functional ability via the Foot Function Index (FFI), ankle range of motion with a goniometer, and gait analysis, with statistical significance set at p < 0.05. This trial registration represents standard prospective clinical research documentation and does not impose any compliance obligations on regulated entities.

“This study aims to evaluate the effectiveness of Low-Dye taping versus calcaneal taping in reducing pain and improving foot function in patients with plantar fasciitis.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 676 changes logged to date.

What changed

The document registers a new randomized controlled clinical trial (NCT07544732) on ClinicalTrials.gov, a database operated by the National Institutes of Health. The trial will enroll 36 participants diagnosed with plantar fasciitis and randomly assign them to receive either Low-Dye taping or Calcaneal taping over a two-week treatment window.

Affected parties include clinical researchers, physiotherapy practitioners, and foot-and-ankle specialists who may encounter findings from this trial upon its completion. The registration does not create any immediate compliance obligations but provides advance notice of upcoming evidence that may inform clinical practice guidelines for plantar fasciitis management.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Effects of Low-Dye Taping Compared to Calcaneal Taping in Patients With Plantar Fasciitis

N/A NCT07544732 Kind: NA Apr 22, 2026

Abstract

Plantar fasciitis is a common musculoskeletal condition characterized by inflammation and microtears of the plantar fascia, leading to heel pain, particularly during initial steps after rest. It negatively impacts gait, mobility, and overall quality of life. Physiotherapy interventions such as stretching, strengthening, electrotherapy, and taping techniques are commonly used for management. Among these, Low-Dye taping and calcaneal taping provide biomechanical support by reducing strain on the plantar fascia and improving foot posture; however, comparative evidence between the two is limited.

This study aims to evaluate the effectiveness of Low-Dye taping versus calcaneal taping in reducing pain and improving foot function in patients with plantar fasciitis. A total of 36 participants will be randomly assigned to either intervention group and treated over a two-week period. Outcome measures will include pain (VAS), functional ability (FFI), ankle range of motion (goniometer), and gait analysis, assessed before and after intervention. Data will be analyzed using SPSS v27, with statistical significance set at p < 0.05.

Conditions: Plantar Fascia

Interventions: Low Dye Taping, Calcaneal Taping

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Physiotherapy research Musculoskeletal treatment
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Healthcare

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!